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tions appeared to limit the extent of secondary transmission of these 
Strains. 
Rapid Typing of Enterncoccus faecalis by PCR 
Using an IS256 Primer 
P.T. Tassios I s z ,  A. Deplano ', E. Ramjrez 
Ryck ', M.J. Struelens 
Libre de Bnutelles, Belgium, 'Dept. ofMicrobiology, Medirnl School, Natl. 
Univ. ofAthens, Greece, 'Dept. de Microbiologia, Fa. de Medecina, 
Odontologia y E.  L! de Ciencias de la Salud, Univ. de Swilla, Spain 
Objectives: To type Enterococntsfaecalis strains rapidly, with optimal 
reproducibihty and discrimination. 
Methods. A crude, lysozyme- and proteinase K-generated bac- 
terial lysate was used duectly in a polymerase chain reaction (PCR) 
whch was evaluated using seventeen high level gentamicin-resistant 
(HLGR) strains, belonging to ten Merent pulsed field gel elec- 
trophoresis (PFGE) types or subtypes. Two primers derived from the 
IS256 sequence, known to exist in several copies in the entemcoccal 
chromosome, were tested, singly or in combination, at four Merent 
anneahng temperatures. 
Results Primer IS256/1 alone and a 50°C annealing tempera- 
ture yielded optimal number, intensity and size range of bands sep- 
arated by a p s e  gel electrophoresis, and discrimination between 
distinct PFGE types. Mean inter-extract and inter-run reproducibil- 
ities were 94.4% and 86.6%, respectively. The method was applied 
satisfactorily to aminoglycoside-susceptible strains. In addition, 113 
nosocomial HLGR E.faecalis strains were shown to belong to 33 am- 
plification profile groups. Where IS256/1 typing gave a pattern of 
only three major and several minor but strain-speclfic bands, primer 
IS256/2 could be used to distinguish further among strains of the 
IS256/1-defined group. 
Conclusions: A rapid PCR protocol, applicable to crude 
de-proteinated bacterial lysates and using a single primer, derived 
from the IS256 sequence, at an annealing temperature of 50 "C 
showed good reproducibility and discriminatory power. The method 
was applied successfully to the typing of susceptible as well as high 
level gentamicin-resistant strains. 
C. Nonhoff', R. de 
'Dept.  of Miaobiology, H6p Erasme, Univ. 
Epidemiology of Enterncoccus faecalis 
Infections in a Greek General Hospital 
J. Papaparaskevas A. Avlami A. Pantazatou A. Vatopoulos ', 
V. Kalapothaki *, M. Tzivn N. L e e  3. 'Microbiology Dpt.  
"Laikon" Gen. Hozpital, Greece, ' o p t .  ofHygien G Epidemioba, 
University ofAthenr Medical School, Greece, 3Dpt. ofMicrobiobgy, 
University ofAthens Medical School, Greece 
Objectives: To study the epidemiology of Enterococcujiecalis infec- 
tions in a general hospital. 
Methods: During a one year period 61 E n t e r o w s  jdis clinical 
isolates were identified in Microbiology Laboratory of "LAIKON" 
General hospital. The susceptibility testing was done by a broth 
microddlution method. The production of B-lactamase was assessed 
with nitrosefine discs. Typing was performed by ERIC-PCR using 
the primer ERIC1. 
Results: All strains were susceptible to vancomycin and te- 
icoplanin. Resistance to ampicillin was found in 4 isolates (6.5%), 
but no isolate prodused B-lactamase. High level resistance to strepto- 
mycin (Str) (MIC > 1024 pg/ml) was found in 11 isolates (18.1%), 
(phenotype compatible with the presence of ANT(6)-1 enzyme). 
High level resistance to gentamycin (Gm) (MIC > 512 pg/ml) was 
found in 1 isolate (1.6%), (presence of AAC (6') + AF'H (2") en- 
zyme). High level resistance to Str and Gm was found in 12 isolates 
(19.6%). The study of the epidemiology of the infections showed 
that: (a) the 12 Gm + Sa resistant isolates were found mainly in two 
internal medicine wards. (b) The resistant strains represented more 
often hospital infections than their sensitive counterparts. Upon t y p  
ing by ERIC-PCR 11 of the 12 s t r a i n s  presented a high degree of 
similarity. On the other hand the susceptible isolates were found to 
be genetically Merent. 
Conclusions: The examined aminoglygosides-resistant Enterococ- 
cusfaecalis isolates seem to be genetically similar, on the contrary the 
sensitives ones were different st rams.  
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I P4591 Epidemiological Analysis by RAPD and PFGE of 
Enterncoccus Strains Isolated from Patients 
with Systemic Infection 
J. Wieczyhka, E. Augustynowicz, U. Lopaciuk, D. Dzierianowska. 
The Children's Memorial Health Institute, Department of Clinical 
Microbidon, Warsaw, Poland 
Objectives: To characterize genotypes of Enterococcal strains iso- 
lated from several clinical specimens from children. 
Methods: Five stains of E. faecalis and 13 strains of E. fae- 
cium isolated from 3 children with systemic infection hospitalized 
in the Children's Memorial Health Institute between 1995-1996 
were used. E. faecalis strains were isolated h m  cerebrospinal fluid 
(3 strains) and prosthetic valve (1 strain). The strains of E. faecium 
were isolated from intestinal fistula (4 strains), dialysis fluid (3 strains). 
blood (2 strains), pus (2 strains), wound swab (1 strain) and peritoneal 
fluid (1 strain). All the s t r a i n s  were typed by use ofrandom amplified 
polymorphic DNA (RAE'D) technique and the results were com- 
pared with SmaI pulsed field gel electrophoresis (PFGE). 
Results: It was strict correlation between two typing systems. 
All strains isolated from one patient had identical RAPD and PFGE 
Conclusion: RAPD and PFGE methods can be ideal tool for 
fingerprints. 
epidemiologic analysis. 
I P461 I Pharmacy Approach to a Case of Acute 
Diantroea with Dehydration in Antalya, Tu&ey 
M. Aktekin, C. Erozgen, L. Donmez. Deparhnent ofhbl ic  Health, 
Medical Faulty, Akdeniz University, Antalya, Turkey 
Objectives: To examine the approaches of the pharmacies to diar- 
rhoeal diseases of childhood in Antalya, T u r k .  
Methods: A fictitious case history of a 10 month infant with an 
acute diarrhoea of three days c h c d l y  identical with vinl diarrhoea 
and moderate dehydration was determined and final semester stu- 
dents of the medical faculty posing themselves as the relatives of the 
infant applied for the advice of the pharmacy attendants. The a p  
proaches of all 214 pharmacies in the Antalya municipality district 
were examined. 
Results Most ofthe pharmacy attendants (57.7%) did not ask any 
question for the Merential diagnosis or to determine the degree of 
dehydration. Only 21.6% of the pharmacy attendants recommended 
to consult a doctor or health center, 44.4% only dqensed a drug, 
23.8% dispensed a drug with ORS (Oral Rehydration Solution). 
Antidiarrhoeals were dispensed by the 67.2% of the pharmacies and 
the ratio for the antibiotia was 14.0%. Also 5.6% of the pharmacy 
attendants advised a reduce in the infant's fluid intake but 17.3% said 
they did not have an idea while 19.2% were advising to stop breast 
feedmg and 7.0% were thoughtless. 
Antibiotic use 107 
Conclusions: The approaches of the pharmacies for acute diar- 
rhoea were determined as inappropriate and harmful. 
lp462/ Improving Antibiotic Prescribing for Treatment 
of Infections in Practice by a Prospective Audit 
Method 
N. Frimodt-Mder ', K. Schzfe;', JJ. Damsgaard ', J. Michelsen', 
A. Munck4. 'Dept. of Clinical Microbiology, Statens Serum Instihrf, 
Copenhagen, Denmark, 'County Council, Roskilde, Denmark, General 
Practice, Roskilde County, Denmark, 4Audit Institute, University of 
Odense, Odense, Denmark 
Objectives: To improve antibiotic prescribing among general prac- 
tioners (GPs) with respect to reduction in use of broad spectrum 
antibiotics such as ampicilhn, tetracykllns and fluoroquinolones. 
Methods: Among the 130 GPs in Roskdde County 46 were in- 
vited by direct mail to participate in the intervention group, while 
the rest served as control. Two survey periods of 3 weeks at the same 
time in jan/feb 12 months apart were performed, where the inter- 
vention group registered their behaviour concerning diagnosis and 
treatment of the 9 most common types of infections. The data was 
evaluated so that each GP received hidher own results compared to 
the rest. After the fust survey a two-day course for the intervention 
group was partaken, where results were &cussed, and the golden 
standards taught by Werent specialists. Following the course GPs 
and experts agreed upon standards regarding diagnosis and treatment 
for each type of infection. Antibiotic prescriptions h m  each GP 
were monitored before and after each of the surveys as parameters 
for measuring the effect of intervention. 
Results and Conclusion: 4000 lnfections were registered at 
each survey. No. of patients treated was reduced with 15.7% (43% 
vs. 51.5%) from 1. to 2. survey, and the number of prescriptions 
decreased with 8.8%. Reduction in prescriptions were: a m p i c h ,  
13%, macrolides, 6%, and quinolones 27%, while penich-V in- 
creased with 15%. This audit method can be highly recommended 
also as a quahty control programme. 
High Antimicrobial Resistance to Common 
Antibiotics-Practice Determinants 
A. Dobardzic, M. Al. Mousawi, R .  Dobardzic, J.I. Mahmeed. 
Kuwait University, Fanuaniya Health Area, Kuwait 
Objective: The objective was to assess the knowledge of general 
pracationers about management of lower urinary tract infections. 
The knowledge about antibiotic therapy has an impact on dinical 
practice and development of bacterial resistance. Bacterial resistance 
to ampicillin, cephalothin and co-trimoxazole has increased to such 
levels that they cannot be used any more as best guess therapy in 
some Kuwaiti regional clinics. 
Methods: The knowledge score about antibiotic therapy of doc- 
tors was assessed by questionnaire. The knowledge score was an- 
alyzed in relation to number of patienu examined daily, working 
experience, age and sex of doctors, and respective susceptibility pat- 
terns. 
Results: 67 (79%) fiom 85 practitioners answered questions about 
their practice. The mean age of physicians was 40 years. The median 
of working experience was 13 years. The lowest number of padents 
examined daily by a doctor was 45. Knowledge of doctors about 
some common practice situations was outdated, e.g. 67% docton 
recommended antibiotic treatment for a period of 7 days or more 
in case of young female pyuria without complicating factors. The 
knowledge score was not related to age, sex, working experience of 
doctors, or number of patients examined per day (multiple regres- 
sion analysis). Factorial analysis was carried out and six factors were 
identified which accounted for 70% of the total variance. 
Conclusion: Results of this study could be useful for practice 
guidelines. Guidelines are necessary to provide a treatment standard 
and to slow down development of bacterial resistance. 
I P464 I Differences in Antimicrobial Usage and 
Expenditures at Four State University Hospitals 
WV Kern ', A.D. Rose I ,  B. Hay I*', R. Muche z ,  ED. Daschner ' 
for the Baden-Wiirttemberg Interuniversity Study Group. 'Inqkt. 
Dis. G Clin. Immunol. Section, Germany, 'Dpt. ofBiostatistiu, Uniu. 
Hosp. Er Med. Ctr., Ulm, Germany, 31nst. ofEnuironm. Med. G. Hosp. 
Hygiene, Freiburg, Germany 
Background: Differences between hospitals (hosps) in the costs for 
antimicrobial (AM) drug therapy per patient (pt) day are often as- 
sumed to be related to inappropriate usage and physician prefer- 
ences of costly drugs rather than to pt variables. We assessed the 
sigdicance of Merences in AM usage and expenditures at 4 state 
university hosps after adjustment for pt variables. 
Methods: The charts of 2254 pts admitted to the m e d d ,  surgi- 
cal and pediatric services were reviewed. Multiple pt variables were 
recorded, and the costs for AM drugs of each case in the week pre- 
cedmg the survey were calculated. The data were then analysed by 
logistic and multiple h e a r  regression to estimate the kequency of 
prescription and costs per pt, adjusted for pt covariates. 
Results: In 30% there was one or more AM drug prescribed in 
the week precedmg the survey. Adjusted prescription rates did not 
W e r  for m e d d  and pediatric pts, but for surgical service pts (F' = 
0.03). Adjusted service-specific costs per pt also differed sigdicantly 
for surgical service pts (€' < 0.001), but not for medical and pediatric 
pts. The adjusted merence between hosps in costs for surgical pts 
was as large as 2.4 fold (95% confidence interval, 1.7 to 3.5). 
Conclusions: There are service-specific sigdicant differences in 
AM drug prescription and costs between hosps that cannot be related 
to Merent case-mixes. The identification of such large diEerences 
might offer ideal opportunities for cost reduction programs. 
lp465) To What Extent can Antibiotic Use be Reduced 
by Preventing Nosocomial Infections? 
P. Gastmeier I ,  D. Sohr ' , M. Schumacher *, F. Daschner 3 ,  
H. Riiden I .  'Institute $Hygiene ofthe Free University of Berlin, 
Germany, 'Institute $Medical Biometry and Medical InfDrmatiu, 
Germany, 31nstihrte of Environmental Medicine and Hospital 
Epidemiology ofthe Albert Ludwig University of Freibua Germany 
Objectives: To describe the linear regression of antibiotic use in 
relation to the presence of infections and to analyze the potential for 
reducing antibiotic use by preventing nosocomial mfections. 
Methods: In a prevalence study on nosocomial infections 
(NIDEP study: Nosocomial Infections in Germany - Surveillance 
and Prevention), a total of 14 966 patients were investigated in me&- 
cal, surgical, gynaecological/obstetrical and intensive care units of 72 
representative German hospitals selected according to size. In addi- 
tion to nosocomial infections, the existence of community-acquired 
infections and the use of antibiotics was recorded for the prevalence 
day by four external investigators. The situation in the 72 hospitals 
investigated was analyzed separately and plotted in a scatter plot. 
Results: An overall prevalence rate of 3.5% was found for nosoco- 
mid mfections, 10.0% for community-acquired infections and 17.7% 
for antibiotic use. The formula of the least square's regression line 
was calculated as y = 7.55 + 0 . 7 3 ~  (x = prevalence of infections, y 
= prevalence of antibiotic use). 
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Conclusions: A 1% reduction in the prevalence of nosocomd 
infections is accompanied by a 0.73% decrease in the prevalence of 
antibiotic use. Accorclmg to the results of the SENIC study (Haley 
RW et al. Am J Epidemiol 1985; 212: 182-205), 32% of all noso- 
comial infections are preventable. Applying this information to the 
NIDEP data may lead to 0.8% reduction in the prevalence of antibi- 
otic use. T h  means an overall reduction in the use of antibiotics of 
4.5%. 
I P466 I Evaluation of Antimicrobial Utilization in the 
M. Bossens', J.P. Sion', T. Figeys ', E Praet', H. Goossens' for 
the Working Group. 'RIZIV/ lNAMI,  Brussels, Belgium, 'University 
Hospital, Antwetp, Begum 
Objective: To rationalize antimicrobial consumption in the Beban 
Hospitals. 
Methods: the National Institute of Health Insurance 
(RIZIV/INAMI) collects data of antimicrobial utilization from hos- 
pital pharmacy records for more than 95% of the patients admitted to 
hospitals in Belgium. Data were analyzed per year, drug form, hospi- 
tal and type of department. Drug expenditures, DDD/100 bed days, 
costhed day and cost/DDD were used. Hospitals were compared 
after adjustment for the number of bed days. 
Results: The total number of DDD's and overall expenditures 
increased by 7 and 24%, respectively, from 1991 to 1993. The fol- 
lowing increases in expenditures were noted in 1993 vs 1991: ticar- 
cillin/dav. acid, 63% imipenem, 41% aztreonam, 54% parented 
glycopeptides, 39%; parented fluoroquinolones (FQ), 188%; oral 
FQ, 45%; and andfungals, 208%. Sigdicant hospital-to-hospital dif- 
ferences were observed. 
Conclusion: In general, there is a decreased use of older and/or 
narrow-spectrum antibiotics and an increased use of new and/or 
broad-spectrum antibiotics. These data should allow improvement 
of antimicrobial prescribing practices in the Belgian hospitals. 
Belgian Hospitals between 1991 and 1993 
Incremental Analysis Treatment of Community 
Acquired Acute Bacterial Bronchitis with 
Amoxycillinclavulanic Acid (ACL) and 
Cotrimoxasol (COT) 
P. JariuSka, I. Schrkter, M. JartuSkovb. Clink cfInf2ct. Diseuses and 
Pediatric Clinic, University cf F!!. &j&ik, Kofice, Slovakia 
We compare two regimens treatment of acute bacterd bronchitis - 
ACL and COT. ACL is most ffequently used drug for treatment of 
acute bacterial bronchitis in Slovakia, because resistance H. influen- 
zae and M. catarrhah to ampiciuln is very hgh. Daily acquisition 
cost of ACL (Augmentin 375 mg, SmithKline Beecham) is 53 Sk 
(Slovak Crowns, 1 DEM - 20.9 Sk), daily acquisition cost of COT 
(Sinersul, Pliva) is 4.64 Sk. VAT is 6%. Average duration of treat- 
ment with ACL was 7.1 days, average duration treatment with COT 
was 10.9 days. Clinical success of treatment was 94% in ACL arm 
and 79% in COT arm. Every additional day of health for patients 
treated with ACL costs 85.75 Sk (incremental cost effectiveness ra- 
tio). We describe other incremental ratios - quality of life, quality 
utility adjusted life days, business utility ratio. 
COMAND A Computer System to Aid Antibiotic 
Choice at UCL Hospitals 
A.P.R. Wilson ', I. Harding'. 'Lkpartment ofclinical Microbiology, 
UCL Hospitak, London, UK, z%kelay's Lid, Devizes, UK 
The use of computer systems to aid the prescription of antibiotics 
promises to reduce errors in selection and dosage but has proved 
a c u l t  to develop and only a few have reached clinical use. A more 
modest PC system has been developed for interactive learning at this 
hospital (COMAND - COMputerised ANtibiotic Database). For 22 
representative parented antibiotics, pubkshed reviews or investiga- 
tions of susceptibility within the last five years or o r w  trials were 
used to compile reliable statistical information (where available) in 
the following areas: in vitro SusceptibJlty to 76 pathogens, PAE, tissue 
concentrations at lobody sites, AUC/MIC ratio, efficacy for 13 sites 
of infection, ease of admitllstration, interactions, serious and minor 
AEs, need for monitoring, cost and evidence of synergy or antag- 
onism to other agents. Weighting factors (adjustable by user) were 
used to produce a score for each antibiotic for a given pathogen and 
infection relating likely susceptibility to tissue concentration, efficacy 
and the other characteristics. If the pathogen or its susceptibhty are 
not known, the user can employ a list of probable fkequencies from 
published series or supply his/her own local information. 
Conclusion: this program will be useful in education of junior 
s d  and possibly, after full evaluation, as an aid to decision making 
in the cknical environment. 
I P469 I Clinical Experience and Economic Justifications 
for the Use of Teicoplanin in Outpatients 
A.P.R. Wilson', I. Harding'. 'Department cf Clinical Microbiology, 
UCL Hospitak, London, UK, 'Thackelay's Lid, Devizes, UK 
T e i c o p b ,  with its long half-Me allowing once-daily admhtra- 
tion, high patient tolerability, activity against pathogens resistant to 
B-lactams, aminoglycosides and quinolones, sigdicant PAE, choice 
of intravenous or intramuscular bolus injection, excellent efficacy 
and safety profile, is an appropriate choice for outpatient use in se- 
rious Gm-positive infection. Review of &cal studies generally 
indicates clinical response rates in excess of 83%. 
In&auon No of No of No of clImcdSuccar % 
Smdm Po Out-pmcna (cvrluablblc prr) 
Boneljoint 5 244 169 148/169 87.6% 
F N E  3 62 62 56/ 59 94.996 
Endourditis 4 74 42 38/ 40 95.007 
SSTI/wiour 3 96 n 46/ 47 97.9% 
mn 2 168 168 141/168 83.907 
OVCd 17 644 513 4291483 88.83k 
Patient tolerability with teicoplanin is high with ~ 2 %  rash and 
local intolerance, el% fever and 0.04% Red Man Syndrome. The 
evidence for the cost-effectiveness of outpatient parented antibiotic 
therapy with teicoplanin is impressive. Authors have reported sub- 
stantial savings in treatment ofbone/joint infections ($8 k/patient/28 
days & up to $60 k/patient), endocardtis ( 4 3 0  Wpatient), lower 
RTI in high risk patients (10 d o n  Lidpatient) and mediastinitis 
($1 k/patient on bed occupancy). 
p] Comparison of Use of Antibiotics in Specific 
Patient Groups 
S. Natsch, Y.A. Hekster, J.WM. van der Meer. University Hospital 
Numegen, 7he Netherlands 
Objectives: To compare the use of Merent therapeutic p u p s  of 
antibiotics in a university hospital, long-term care fadties and in 
out-patients in the Netherlands 
Methods: The amount of antibiotics used was measured in de- 
fined daily doses (DDD). The dasufication of the drugs was per- 
formed according to the anatomical therapeutic chemical (ATC) 
classification. Sources of information were the pharmacy statistic of 
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the university hospital, purchase statistics h m  six long-term care 
facilities in the Nijmegen region and data published by the insurers 
in Netherland’. 
Results: In acute care, penicillins (PEN) make up 58.6% of 
the antibiotics, cephalosporins (CEF) 12%, cotrimoxazole (SXT) 
9.1% and quinolones (QUIN) 6.6%, whereas tetracyches (T) and 
macrolides (M) are almost never used. In longterm-care facilities, 
PEN make up only 25.3% whereas T amount to 24.9% and QUIN 
to 27.4%. In out-patients, PEN make up 42.3%, T 32.3%, SXT 
10.3% and QUIN and M 6.8% each. 
Conclusions: The use of different groups of antibiotics differs 
greatly according to the population analysed. To be able to per- 
form these comparisons, it is very important to use the standardized 
ATC/DDD classification system without any adaptation to local sit- 
uations. Surveillance and intervention programs must then be targed 
to the drugs most used in a group of patients. In a next step, these 
data should be linked to antibiotic resistance surveillance data. 
References 
111 GI Peilingen 1994, Kengetallen firmaccutirche hulp Ziekenfon&nad/Geneesrmddelen 
Inforrmdc Project (GIP) Amstelveen, december 1995 
w] Is There a Need for Another Broad-spectrum 
Antibiotic in Your Institution? 
S .  Harbarth, V Gabriel, D. Pittet, J. Garbino, D. Lew. University 
Hospitak of Geneva (HUG), Geneva, Switzerland 
Objective and Design: To assess the need and possible indications 
for a new broadspemum cephalosporin (cefepime, FEP), two stud- 
ies-one cohort and one nonrandomized open-label study-were per- 
formed over a 17-mo period at HUG. We studied 1135 patients, fol- 
lowed consecutively by our Infectious Diseases Division (IDD). A data 
collection form was used to determine the potential use of FEP in 
each patient. A computer data-base containing information on all pa- 
tients followed by the IDD served as back-up for analysis ofthe results. 
Results: Among 1135 observed patients, in 256 c&es (22.6%) 
FEP could have been chosen as an alternative to broadspectrum an- 
tibiotics @A) used in HUG (eg. imipenem, piperacillin/tazobactam, 
ceftazidime, ciprofloxacin). Among 70 patients entering the 
open-label study, 12 cases of failure (17%) and 4 cases of serious 
adverse events related to FEP (6%) occured. Seen the low cost of 
FEP in Switzerland, there would have been substantial savings for 
the hospital pharmacy, if FEP had been used as first-line treatment. 
Nevertheless, we could not observe any definite clinical or micro- 
biological advantages of FEP compared to already introduced BA, 
exepting two conditions: first, FEP allowed outpatient treatment in 
a s m a l l  subgroup of patients with severe Gram-negative infections. 
Second, seen our resistance data concerning Enterobacter spp. FEP is 
filling a therapeutic need to overcome problems of resistance with 
h s  microorganism. 
Conclusions: Consultation by an IDD may be a useful tool to 
control the overuse of new BA. Only clear scientific and pharma- 
coeconomical considerations should lead to further introduction of 
new BA. 
I P472 I Two Years’ Experience and Saving on Changed 
Cephaiosporin Use and intravenous (IV) to Oral 
switch 
M. Rahman. Microbiology Department, King’s Mill Hospital, Mansfield, 
England 
Objectives: To achieve good health care and costs reduction by 
changed use of cephalosporins. 
Methods: Initial discussions were held in 1994 between the Med- 
ical Microbiologist (MM) and pharmacists on uses and costs of 
cephalosporins in this hospital. Based on data on effkacy, safety and 
costs a proposal was made for using cefuroxime (rv) replacing most 
of cefotaxime and for changing IV cefuroxime after 2-3 days to oral 
cefixime. This was agreed by various committees for introduction 
from 1995. Publicity and monitoring the changes were maintained 
by the MM and pharmacists. Uses and costs were reviewed at the 
end of 1996. 
Results: No problem was experienced while patient and scaff 
convenience was noted. Saving obtained on drug costs was about 
6105,000, consisting of 634,768 on replacing most of cefotaxime 
with IV cefuroxime and u0 ,187  on IV to oral cefixime switch. 
There were additional savings whch could not be quanhfied. 
Conclusion: Improved patient care and cost saving was possible 
by changing cephalosporins and IV to oral switch. 
Gentamicin Policy Compromised in Bulgaria 
E. Keuleyan, N. Hadjieva, B. Markova, F? Pencheva, E. Savov, 
L. Sechanova, M. Sredkova, F? S o h v a ,  I. Hajduchka, 
M. Kubateva. Medical Universia S o h ,  Bulgaria 
As gentamicin (Gen) was introduced in Bulgaria in 1972, our aim 
was to assess hquency and mechanisms of resistance (R) and their 
consequences. Worldwide and Bulgarian studies were compared. 
Data h m  9 hospitals from different places obtained by WHOnet 
or local programmes were analysed. 
Aminoglycoside-modfymg enzymes (AGME) detected by Phos- 
phocellulose paper binding assay in 3 stady-periods were reviewed. 
In the beginning of 1980’s Gen, tobramycin (Tob), netilmicin (Net) 
and amikacin (Akn) Susceptibility (S) in Gr bacteria were 80%, 86%, 
96%, and 98%, respectively, being comparable with other countries. 
From the middle of 80’s R to Gen, already stabilised in the world, 
continued to grow in Bulgaria. Now S to Gen in enterobacteria is 
62%, 40% in P amginosa and 26% in Acinetobacter. Sigmficant dif- 
ferences were found for S of different:: species, materials, clinics 
(ICU), hospitals. Akn S is conserved, with exception in Acineto- 
bactq I! amginosa, Enterobacter and Senatia. Trends to reduction of 
Akn S were found for Acinetobacter: y = 76.1-5.56 n (r = -0.8, 
P < 0.05) and E .  cloacae. In 1981-83 study of AGME, ANT (2”) 
was predominant, followed by AAC(3)V) and 11. In 1984-86 study 
AAC(3)IV was predominant, followed by ANT&”) and AAC(3)II. 
Several combinations and 3 different Akn ME appeared: AAC(3)IV 
+ ANT(2”)II + APH(3’)VIII. In 1991’s AG R was more com- 
plex: AAC(6’)I + AAC(3)IIAV + ANT(2”) were the predominant 
combinations, followed by other combinations and a few ANT(2”). 
Hence, evolution of R found by G. Mdier & AG study group was 
also seen in Bulgaria, where AG use is 30% of antibiotics, and Gen 
is 75% of it. More prudent policy, incl. AG rotation and isepamicin 
introducing, but preserving for seriously ill and immunosuppressed 
patients is needed. The future of the potent aminoglycoside therapy 
against prominent nosocomial pathogens, is in doctors hands. 
F] Antibiotic Restriction Policy in Greece: Time to 
M. Lelekis, D. Mylona-Petropoulou, D. Polymeros, 
A. Strouza-Koutsougera, C. Karakatsani, J. Kosmidis. First Dept of 
Medicine and Dept of Microbiology, The General Hospital ofrlthens, 
Greece 
In 1990 we recorded a si&icant increase of Kfebsiella resistance in 
our hospital. This correlated well with an almost 3-fold increase in 
ceftazidime (CAZ) consumption in the precedmg 4 years. An antibi- 
Expand it? 
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otic restriction policy was implemented at that time. In order to eval- 
uate the efficacy of &IS policy we monitored the resistance of Kleb- 
siella s t n i n s  isolated h m  September to November 1996. Compared 
to 1990 a rather sigdicant fall of resistance rates was observed for 3d 
gen cephs and aztreonam (ATM) (CAZ: from 52% to 33%, ATM: 
52+34%). Resistance remained stable for co-amoxiclav (27+26%) 
and imipenem (2+ 1.3%). Cefoxitin resistance already relatively low 
in 1990, decreased hrther (19+11%). Among aminoglycosides, re- 
sistance rates decreased for gentamicin (31+12%) but remained sta- 
ble for amikacin (27+24%). Netilmicin (NET) not tested in 1990 
had a 33% resistance rate in 1996. It is worthnoting that a fall in 
CAZ consumption was observed between 1990 and 1996 while 
AK and NET are the mostly prescribed aminoglycosides (which 
are not under restriction). Ciprofloxacin and the newly introduced 
piperacillin-tazobactam and cefepime showed a useful efficacy with 
resistance rates 12%, 13% and 17% respectively. It seems that while 
being on the right side it's a long way to acheve the pals of our 
policy. However maybe we should do something for aminoglycoside 
resistance. 
P475 I Trends of UTI Therapy in the Community, 1992 
to 1996 
Th.A. Peppas, D. Voutsinas, I. Tsakanikas, A. Sodropoulos, 
E Matsouka, Ch. Kamilatos, S. Pappas, N. Galanakis. General 
Hospital Nikaea, Piraeus, Greece 
Objectives: To assess prescription trends and their economic impact 
in the therapy of urinary tract infections (UTI) in the community 
over a 5 year period. 
Methods: This prospective study recorded 2.773 antimicrobial 
prescriptions dispensed in 3 Athens area pharmacies between Jan 
1992 and Dec 1996. Antimicrobial category, brand, form, quantity 
and indication as well as the retail price were registered and entered 
in an IBM compatible PC, using the EPI5-Info (WHO/CDC, 1991) 
epidemilogy and analysis pack. 
Results: Inmation of UTI was present in 37312.773 prescrip- 
tions (13.5%), second only to respiratory tract infections. The most 
fhquently prescribed category for UTI were the 4F-quinolones 
[OJ(54.1%) followed by cotrimoxazole (20.5%) and aminoglycosides 
(6.8%). Norfioxacin was the most popular choice (81% of the pre- 
scribed Q, mean therapy duration being 9.2 days). The aminogly- 
cosides were favoured by urologists for a mean regimen length of 
4.8 days. The rise of Q was continuous rising h m  33.3% in 1992 
to 60.5% of all UTI prescriptions in 1996. The mean cost of an- 
timicrobial was 5.271 GDR, (-L13) substantially higher than other 
indications. The annual mean antimicrobial cost for UTI prescrip- 
tions rose from 2.818 GDR W) in 1992 to 5.855 GDR g14.6) in 
1995. The choice of Q was rarely, if ever, justified by the provided 
information. 
Conclusions: The dominance, in a great extent, of Q in the ther- 
apeutic choices of UTI in the community is particularly worrying, 
for ecology and resistance considerations mainly, but is also a cause 
for economic concern. The setting and keeping of guidelines for 
proper antimicrobial usage, therefore, seems a major priority, with 
multiple benefits. 
I P476 1 Pharmacoeconomics of Carbapenem Delivery 
RJ. Plumridge. Fremantle Hospital and Health Service, Fremantle, 
Western Australia, Australia 
Objectives: ImipenendCilastatin (IC) and Meropenem have similar 
clinical effectiveness and efficacy. The administration of these antibi- 
costs 
otics Mer,  however, in that IC must be infused whereas Meropenem 
can be given by rapid injection or infusion. This s t u d y  determined 
the differences in preparation and admirustration time, and the total 
delivery costs of these carbapenems. 
Methods: Activities for intravenous dose preparation and a h -  
istration (IC 500 mg/500 mg and 1 g/l  g infusion, and Meropenem 
500 mg and 1 g rapid injection and &ion) were identifled from 
hospitaJ nursing procedures and the time required by a registered 
nurse was determined using a stopwatch-timed technique. Based on 
the average weighted nurse salary the respective labour costs were 
calculated and consumable costs added to determine the total deliv- 
ery cost for the two antibiotics. These differences were subjected to 
Results:Meropenem reduced labour requirements by between 
33% and 76% (mean time: rapid injection 14.82 and 15.62 min- 
utes; infusion 15.42 and 17.08 minutes) compared to IC (&ion: 
20.59 and 27.50 minutes) for the respective doses. Total delivery 
costs (Australian dollars) were reduced by between 21% and 117% 
by Meropenem (rapid injection $6.26 and $6.86; lnfusion $9.24 and 
$9.99) compared to IC (infusion $11.23 and $14.52). These diEer- 
ences were statistically sigdcant (p < 0.0005) 
Conc1usion:Meropenem has substantial delivery cost advantages 
over Imipenem/Cilastatin, especially when admhstered by rapid 
injection. Meropenem appears to be the preferred formulary car- 
bapenem based on cost minimisation dose delivery criteria. 
statistical analysis. 
General infection control issues 
I P477 I Targeting Department-Specific Infection Control 
Training Priorities 
S. Alfandari I ,  B. Guery I ,  V. Lefebvre ' , M. Vanhuffel ' , 
C. Krembe12, B. Morin *, G. Beaucaire I .  'Centre Hospitaliq 
Tourcoing, France, ZInsfitut Pasteur, Lille, France 
Objectives: To define department-specific priorities in infection 
control training and policies. 
Methods: A structured questionnaire developed by the Lille Pas- 
teuz Institute was send to all department heads and chef nurses. 
Ninety items (three-choice) were proposed in eight categories. An- 
swers were assigned predetermined coeffiaents. Grade points were 
summed by category and rated zero to 20. 
Results: All 20 departments filled the questionnaire excepted 
one department chief. Knowledge levels were considered sabsfjmg 
(> 10/20) in the following categories: knowledge of the hospital in- 
fection control unit, isolation procedures, laundry, waste Cksposd and 
cksinfection/steriation. They were insufficient for hand washing 
(4.&6.7/20), and catering (5.8-7.3/20). Department routine clean- 
ing was well known by chief nurses (12.8120) but not by department 
heads (8.1/20). The overall correlation chef nurse/department head 
was ~ 6 0 %  in 75% of cases. Correlation between department chief% 
was >70% in 37% of cases and 260% in 89% of cases. 
Conclusions: T h  questionnaire helps estabhhing depart- 
ment-specific training priorities. In 1997, hand washing will be the 
priority in all but three departments. 
I P478 I Physicians' Compliance to Hand Washing and 
Th.A. Peppas, D. Voutsinas, E. Dimitriadou, 0. Apostolou, 
N. Galanalus. ID Chit, General Hospital afNiha,  Pimeus, Greece 
Objectives: To assess the compliance of physicians to simple, yet 
Universal Precautions 
